hypoproliferative thrombocytopenia
Showing 1 - 25 of 634
Hypoproliferative Thrombocytopenia Trial in Singapore (Control arm receiving normal (never before frozen) platelets as per
Completed
- Hypoproliferative Thrombocytopenia
- Control arm receiving normal (never before frozen) platelets as per current clinical practice
- Treatment arm receiving cryopreserved platelets
-
Singapore, SingaporeSingapore General Hospital
Sep 23, 2021
Hematologic Malignancies, Hypoproliferative Thrombocytopenia Trial in United States (Mirasol platelets (MIR PLTs), Reference
Terminated
- Hematologic Malignancies
- Hypoproliferative Thrombocytopenia
- Mirasol platelets (MIR PLTs)
- Reference platelets (REF PLTs)
-
Washington, District of Columbia
- +9 more
Jul 28, 2021
ROTEM and Platelet Indices in Thrombocytopenic Patients .
Not yet recruiting
- Patients With Low Platelets Counts
- (no location specified)
Apr 29, 2023
Chemo-induced Thrombocytopenia Trial in Shanghai (QL0911)
Completed
- Chemotherapy-induced Thrombocytopenia
-
Shanghai, Shanghai, ChinaShanghai East Hospital
May 5, 2023
Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura
Not yet recruiting
- ITP - Immune Thrombocytopenia
- eltrombopag and romiplastim
- (no location specified)
Nov 16, 2023
Chemo-induced Thrombocytopenia Trial in Shanghai (QL0911, Placebo)
Recruiting
- Chemotherapy-induced Thrombocytopenia
- QL0911
- Placebo
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Sep 21, 2022
Outcome of Thrombocytopenia in ICU Patients
Not yet recruiting
- Thrombocytopenia
- (no location specified)
Jul 15, 2023
Thrombocytopenia Purpura, Chronic HBV Infection Trial in Tianjin (Eltrombopag)
Completed
- Thrombocytopenia Purpura
- Chronic HBV Infection
-
Tianjin, Tianjin, ChinaEthics Committee of Blood disease hospital, Chinese Academy of M
Jan 24, 2023
Study of Severe Fever With Thrombocytopenia Syndrome
Recruiting
- Severe Fever With Thrombocytopenia Syndrome
-
Guangshui, Hubei, China
- +7 more
Aug 21, 2023
Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)
Recruiting
- Myelofibrosis
-
Saint Louis, MissouriWashington University School of Medicine
Oct 26, 2022
Ketogenic Diet Trial (Strict ketogenic diet group, Cyclic ketogenic diet group, Autonomous ketogenesis group)
Not yet recruiting
- Ketogenic Diet
- Strict ketogenic diet group
- +2 more
- (no location specified)
Oct 26, 2023
Systemic Lupus Erythematosus Trial (Telitacicept, conventional therapy, Placebo)
Not yet recruiting
- Systemic Lupus Erythematosus
- Telitacicept
- +2 more
- (no location specified)
Jun 26, 2023
Connective Tissue Diseases, Thrombocytopenia Trial in China (Telitacicept, Placebo)
Not yet recruiting
- Connective Tissue Diseases
- Thrombocytopenia
- Telitacicept
- Placebo
-
Hefei, Anhui, China
- +21 more
Aug 18, 2023
Chronic Primary Immune Thrombocytopenia (ITP) Trial in China (Qrelabrutinib, Placebo)
Not yet recruiting
- Chronic Primary Immune Thrombocytopenia (ITP)
- Qrelabrutinib
- Placebo
-
Bengbu, Anhui, China
- +13 more
Aug 15, 2023
Chemo-Induced Thrombocytopenia Trial (Hetrombopag)
Not yet recruiting
- Chemotherapy-Induced Thrombocytopenia
- (no location specified)
Jul 24, 2023
Clinical Performance Evaluation of T-TASĀ®01 HD Chip
Recruiting
- Thrombocytopenia
- T-TAS 01 HD Assay
-
San Francisco, California
- +5 more
Oct 11, 2023
Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])
Not yet recruiting
- Immune Thrombocytopenia
- Treatment
- Obinutuzumab Injection [Gazyva]
-
Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Aug 9, 2023
Chemo-Induced Thrombocytopenia Trial (Hetrombopag Olamine)
Not yet recruiting
- Chemotherapy-Induced Thrombocytopenia
- Hetrombopag Olamine
- (no location specified)
Jul 5, 2023
Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])
Not yet recruiting
- Immune Thrombocytopenia
- Treatment
- Obinutuzumab Injection [Gazyva]
-
Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital, Chinese Aca
Oct 17, 2023
Chemo-induced Thrombocytopenia, Eltrombopag Trial in Tianjin (Eltrombopag)
Recruiting
- Chemotherapy-induced Thrombocytopenia
- Eltrombopag
-
Tianjin, Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Jan 24, 2023
Chemo-induced Thrombocytopenia, Herombopag Trial in Tianjin (Herombopag)
Recruiting
- Chemotherapy-induced Thrombocytopenia
- Herombopag
-
Tianjin, Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Jan 24, 2023
Chemo-induced Thrombocytopenia, Avatrombopag Trial in Tianjin (Avatrombopag)
Recruiting
- Chemotherapy-induced Thrombocytopenia
- Avatrombopag
-
Tianjin, Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Jan 24, 2023
Chemo-Induced Thrombocytopenia Trial (Hetrombopag, Hetrombopag plus Placebo, Placebo)
Not yet recruiting
- Chemotherapy-Induced Thrombocytopenia
- Hetrombopag
- +2 more
- (no location specified)
May 17, 2023
Thrombocytopenia, Hepatocellular Carcinoma Trial in Guangzhou (Avatrombopag)
Not yet recruiting
- Thrombocytopenia
- Hepatocellular Carcinoma
-
Guangzhou, Guangdong, ChinaThe Second Affiliated Hospital of Guangzhou Medical University
Aug 17, 2023